Patents by Inventor Virginie Joulin

Virginie Joulin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for preventing cancer metastasis
    Patent number: 9161944
    Abstract: The present invention relates to the use of a specific family of glycerolipid compounds of formula (I) described in the detailed description or the manufacture of a medicament for the prevention or for the treatment of cancer metastasis.
    Type: Grant
    Filed: February 17, 2011
    Date of Patent: October 20, 2015
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE BRETAGNE OCCIDENTALE (U.B.O.), UNIVERSITE FRANCOIS-RABELAIS DE TOURS
    Inventors: Christophe Vandier, Philippe Bougnoux, Aurelle Chantome, Bernard Corbel, Alban Girault, Jean-Pierre Haelters, Virginie Joulin, Marie Potier-Cartereau, Gaelle Simon
  • Method for Preventing Cancer Metastasis
    Publication number: 20130029925
    Abstract: The present invention relates to the use of a specific family of glycerolipid compounds of formula (I) described in the detailed description or the manufacture of a medicament for the prevention or for the treatment of cancer metastasis.
    Type: Application
    Filed: February 17, 2011
    Publication date: January 31, 2013
    Applicants: UNIVERSITE DE BRETAGNE OCCIDENTALE (U.B.O.), INSERM ( INSTITUT NATIONAL DE LA SANTA ET DE LA RECHERCHE MEDICALE), UNIVERSITE FRANCOIS-RABELAIS DE TOURS
    Inventors: Christophe Vandier, Philippe Bougnoux, Aurelie Chantome, Bernard Corbel, Alban Girault, Jean-Pierre Haelters, Virginie Joulin, Marie Potier-Cartereau, Gaelle Simon
  • Method for the in vitro screening of anti-cancer compounds that inhibits SK3 activity, and said anti-cancer compounds
    Patent number: 8084196
    Abstract: The present invention relates to methods for the in vitro screening of an anti-metastatic compound that inhibits activity, methods for determining in vitro the presence or absence of a metastatic cancer in a subject by quantifying SK3 activity, methods for the in vitro assessment of the progression of the metastatic property of a cancer by quantifying SK3.
    Type: Grant
    Filed: August 3, 2007
    Date of Patent: December 27, 2011
    Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Marie Potier, Christophe Vandier, Virginie Joulin
  • METHOD FOR THE IN VITRO SCREENING OF ANTI-CANCER COMPOUNDS THAT INHIBITS SK3 ACTIVITY, AND SAID ANTI-CANCER COMPOUNDS
    Publication number: 20090311693
    Abstract: The present invention relates to methods for the in vitro screening of an anti-metastatic compound that inhibits activity, methods for determining in vitro the presence or absence of a metastatic cancer in a subject by quantifying SK3 activity, methods for the in vitro assessment of the progression of the metastatic property of a cancer by quantifying SK3.
    Type: Application
    Filed: August 3, 2007
    Publication date: December 17, 2009
    Applicant: ISERM(Institut National de la Sante et de la Recherche Medicale
    Inventors: Marie Potier, Christophe Vandier, Virginie Joulin